Brief: Arrivent Announces Pricing Of Upsized Initial Public Offering
Jan 25 (Reuters) - Arrivent Biopharma Inc AVBP.O :
* ARRIVENT ANNOUNCES PRICING OF UPSIZED INITIAL PUBLIC
OFFERING
* PRICING OF ITS UPSIZED INITIAL PUBLIC OFFERING OF 9.7
MILLION
SHARES OF ITS COMMON STOCK AT A PRICE OF $18.00 PER SHARE
Source text for Eikon: ID:nGNX7f5PxB
Further company coverage: AVBP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ArriVent BioPharma
See all newsBrief: Arrivent Announces First Patient Dosed With Novel Tetravalent Muc16/Napi2b Dual Target Adc, Arr-002
US RESEARCH ROUNDUP-Allstate, Caribou Biosciences, Zscaler
U.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
U.S. STOCKS ON THE MOVE-Constellation Energy, AMD
ArriVent falls after lung cancer drug misses late-stage trial goal